Jane Street Group LLC Sells 58,870 Shares of Progyny, Inc. (NASDAQ:PGNY)

Jane Street Group LLC cut its stake in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 43.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 76,660 shares of the company's stock after selling 58,870 shares during the quarter. Jane Street Group LLC owned about 0.09% of Progyny worth $1,322,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in PGNY. River Road Asset Management LLC bought a new stake in shares of Progyny in the 4th quarter valued at about $25,529,000. Pacer Advisors Inc. raised its stake in shares of Progyny by 47.5% during the 4th quarter. Pacer Advisors Inc. now owns 3,676,200 shares of the company's stock worth $63,414,000 after acquiring an additional 1,183,558 shares in the last quarter. Fort Washington Investment Advisors Inc. OH raised its stake in shares of Progyny by 90.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company's stock worth $25,319,000 after acquiring an additional 695,740 shares in the last quarter. Barclays PLC lifted its position in Progyny by 95.7% during the fourth quarter. Barclays PLC now owns 1,382,205 shares of the company's stock valued at $23,843,000 after acquiring an additional 676,048 shares during the last quarter. Finally, Baillie Gifford & Co. lifted its position in Progyny by 52.2% during the fourth quarter. Baillie Gifford & Co. now owns 1,332,690 shares of the company's stock valued at $22,989,000 after acquiring an additional 456,853 shares during the last quarter. 94.93% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. BTIG Research raised Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price target on the stock in a research report on Monday, March 31st. Canaccord Genuity Group dropped their target price on Progyny from $23.00 to $21.00 and set a "hold" rating on the stock in a research note on Monday, May 12th. Bank of America upped their target price on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. Finally, JPMorgan Chase & Co. increased their price target on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research note on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $23.45.

Progyny Stock Performance

Progyny stock opened at $21.50 on Tuesday. The business's 50-day simple moving average is $22.11 and its two-hundred day simple moving average is $19.84. The company has a market cap of $1.84 billion, a PE ratio of 37.07, a PEG ratio of 2.39 and a beta of 1.37. Progyny, Inc. has a fifty-two week low of $13.39 and a fifty-two week high of $30.42.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm had revenue of $324.04 million during the quarter, compared to analysts' expectations of $307.86 million. During the same quarter in the prior year, the company earned $0.17 EPS. Progyny's quarterly revenue was up 16.5% on a year-over-year basis. As a group, analysts predict that Progyny, Inc. will post 0.6 EPS for the current fiscal year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Want to see what other hedge funds are holding PGNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Progyny, Inc. (NASDAQ:PGNY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.